Autolus Therapeutics Plc
AUTL
Revenue
269.00k
▼-24.00k▼-8.19%
9 Months ChangeAssets
853.62M
▼-47.82M▼-5.30%
3 Months ChangeLiabilities
325.78M
▲6.37M▲1.99%
3 Months ChangeFree Cash Flow
-41.05M
▲4.99M▲10.85%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-26
Form 8-K
ID: 0001730463-24-000110
2024-09-19
Form 8-K
ID: 0001730463-24-000104
2024-09-13
Form 8-K
ID: 0001730463-24-000099
2024-08-08
Form 10-Q
ID: 0001730463-24-000093
2024-08-08
Form 8-K
ID: 0001730463-24-000088
2024-06-28
Form 8-K
ID: 0001730463-24-000076
2024-06-05
Form 8-K
ID: 0001730463-24-000074
2024-06-03
Form 8-K
ID: 0001730463-24-000070
2024-05-17
Form 10-Q
ID: 0001730463-24-000064
2024-05-17
Form 8-K
ID: 0001730463-24-000059